BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kuo CL. Etiopathogenesis of acquired cholesteatoma: prominent theories and recent advances in biomolecular research. Laryngoscope 2015;125:234-40. [PMID: 25123251 DOI: 10.1002/lary.24890] [Cited by in Crossref: 69] [Cited by in F6Publishing: 62] [Article Influence: 8.6] [Reference Citation Analysis]
Number Citing Articles
1 Nagel J, Wöllner S, Schürmann M, Brotzmann V, Müller J, Greiner JF, Goon P, Kaltschmidt B, Kaltschmidt C, Sudhoff H. Stem cells in middle ear cholesteatoma contribute to its pathogenesis. Sci Rep 2018;8:6204. [PMID: 29670222 DOI: 10.1038/s41598-018-24616-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
2 Minami SB, Mutai H, Suzuki T, Horii A, Oishi N, Wasano K, Katsura M, Tanaka F, Takiguchi T, Fujii M, Kaga K. Microbiomes of the normal middle ear and ears with chronic otitis media. Laryngoscope 2017;127:E371-7. [PMID: 28397271 DOI: 10.1002/lary.26579] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 5.2] [Reference Citation Analysis]
3 Lee A, Sulica L, Aylward A, Scognamiglio T. Sulcus vocalis: A new clinical paradigm based on a re-evaluation of histology: Sulcus Vocalis. The Laryngoscope 2016;126:1397-403. [DOI: 10.1002/lary.25732] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
4 Kuo CL, Shiao AS, Chen CH, Lien CF. Multidimensional staging system for pediatric acquired cholesteatoma: A 30-year verification data. Auris Nasus Larynx 2016;43:387-94. [PMID: 26443626 DOI: 10.1016/j.anl.2015.09.007] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
5 Jackler RK, Maria PL, Varsak YK, Blevins NH, Nguyen A. In response to A new theory on the pathogenesis of acquired cholesteatoma: Mucosal traction. Laryngoscope 2016;126:E133. [PMID: 26421689 DOI: 10.1002/lary.25699] [Reference Citation Analysis]
6 Hara S, Kusunoki T, Nakagawa H, Toyoda Y, Nojiri S, Kamiya K, Furukawa M, Takata Y, Okada H, Anzai T, Matsumoto F, Ikeda K. Association Between Earwax-Determinant Genotypes and Acquired Middle Ear Cholesteatoma in a Japanese Population. Otolaryngol Head Neck Surg 2022;166:139-45. [PMID: 33722103 DOI: 10.1177/01945998211000374] [Reference Citation Analysis]
7 Lipschitz N, Earl BR, Cripe TP, Samy RN. Oncolytic virotherapy: a potential therapeutic approach for cholesteatoma. Curr Opin Otolaryngol Head Neck Surg 2020;28:281-5. [PMID: 32833886 DOI: 10.1097/MOO.0000000000000651] [Reference Citation Analysis]
8 Ocal R, Kargin Kaytez S, Yumusak N, Akkoca O, Celik H, Arslan N. The Effect of Oral Montelukast Administration in Cholesteatoma Development and Inflammation: An Experimental Animal Model. Otol Neurotol 2021;42:e568-72. [PMID: 33481545 DOI: 10.1097/MAO.0000000000003061] [Reference Citation Analysis]
9 Fan X, Liu Z, Ding C, Chang Z, Ma Q. The value of turbo spin-echo diffusion-weighted imaging apparent diffusion coefficient in the diagnosis of temporal bone cholesteatoma. Clinical Radiology 2019;74:977.e1-7. [DOI: 10.1016/j.crad.2019.08.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
10 Kuo CL, Chang NH, Shiao AS, Lien CF, Huang HL, Lin SH, Chang WP. Depression and cholesteatoma: Preliminary findings from a nationwide population-based retrospective cohort study. J Affect Disord 2016;194:222-5. [PMID: 26852187 DOI: 10.1016/j.jad.2016.01.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
11 Şahin MM, Sözmen Cılız D, Çayönü M, Kayalı Dinç S, Akbal Ş, Boynueğri S, Eryılmaz A. Magnetic Resonance Imaging of the Eustachian Tube and the Paratubal Structures in Patients with Unilateral Acquired Cholesteatoma. J Int Adv Otol 2020;16:373-7. [PMID: 33136019 DOI: 10.5152/iao.2020.7508] [Reference Citation Analysis]
12 Liu D, Ma X. MiR-508-3p promotes proliferation and inhibits apoptosis of middle ear cholesteatoma cells by targeting PTEN/PI3K/AKT pathway. Int J Med Sci 2021;18:3224-35. [PMID: 34400892 DOI: 10.7150/ijms.60907] [Reference Citation Analysis]
13 Kuo CL. The strategy for management of tympanic membrane retractions. Auris Nasus Larynx 2016;43:715-6. [PMID: 26920071 DOI: 10.1016/j.anl.2015.12.018] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
14 Østevik L, Rudlang K, Holt Jahr T, Valheim M, Njaa BL. Bilateral tympanokeratomas (cholesteatomas) with bilateral otitis media, unilateral otitis interna and acoustic neuritis in a dog. Acta Vet Scand 2018;60:31. [PMID: 29788991 DOI: 10.1186/s13028-018-0386-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Li Q, Ao Y, Yu Q, Zhou S. Role of Autophagy in Acquired Cholesteatoma. Otol Neurotol 2019;40:e993-8. [PMID: 31663994 DOI: 10.1097/MAO.0000000000002404] [Reference Citation Analysis]
16 Chung JH, Lee SH, Park CW, Kim KR, Tae K, Kang S, Oh YH, Pyo JY. Expression of Apoptotic vs Antiapoptotic Proteins in Middle Ear Cholesteatoma. Otolaryngol Head Neck Surg 2015;153:1024-30. [DOI: 10.1177/0194599815591810] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
17 Uzun T, Çaklı H, Coşan DT, İncesulu ŞA, Kaya E, Çalış İU, Yıldız E. In vitro study on immune response modifiers as novel medical treatment options for cholesteatoma. Int J Pediatr Otorhinolaryngol 2021;145:110743. [PMID: 33933986 DOI: 10.1016/j.ijporl.2021.110743] [Reference Citation Analysis]
18 Shih CP, Lee JT, Chen HK, Lin YC, Chen HC, Lin YY, Kuo CY, Chen YT, Wang CH. Comparison of changes in mitochondrial bioenergetics between keratinocytes in human external auditory canal skin and cholesteatomas from normoxia to hypoxia. Sci Rep 2018;8:125. [PMID: 29317713 DOI: 10.1038/s41598-017-18536-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
19 Xie S, Pan Z, Yin T, Ren J, Liu W. Expression of PTHrP and RANKL in acquired middle ear cholesteatoma epithelium. Acta Otolaryngol 2020;140:351-5. [PMID: 32108533 DOI: 10.1080/00016489.2020.1717609] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Hu Y, Teh BM, Hurtado G, Yao X, Huang J, Shen Y. Can endoscopic ear surgery replace microscopic surgery in the treatment of acquired cholesteatoma? A contemporary review. Int J Pediatr Otorhinolaryngol 2020;131:109872. [PMID: 31945733 DOI: 10.1016/j.ijporl.2020.109872] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
21 O TM. Medical Management of Acute Facial Paralysis. Otolaryngol Clin North Am 2018;51:1051-75. [PMID: 30297178 DOI: 10.1016/j.otc.2018.07.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
22 Casazza G, Carlson ML, Shelton C, Gurgel RK. The Medially-Invasive Cholesteatoma: An Aggressive Subtype of a Common Pathology. Ann Otol Rhinol Laryngol 2021;130:38-46. [PMID: 32602346 DOI: 10.1177/0003489420937731] [Reference Citation Analysis]
23 Yeşilova M, Görür K, Ismi O, Özcan C, Büyükafşar K. The Role of Rho/Rho-Kinase Pathway in the Pathogenesis of Cholesteatoma. Otol Neurotol 2017;38:516-20. [PMID: 28288476 DOI: 10.1097/MAO.0000000000001344] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
24 Sweeney AD, Hunter JB, Haynes DS, Driscoll CL, Rivas A, Vrabec JT, Carlson ML. Iatrogenic cholesteatoma arising from the vascular strip: Vascular Strip Cholesteatoma. The Laryngoscope 2017;127:698-701. [DOI: 10.1002/lary.26093] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
25 Jung J, Jung SY, Kim MG, Kim YI, Kim SH, Yeo SG. Comparison of Autophagy mRNA Expression between Chronic Otitis Media With and Without Cholesteatoma. J Audiol Otol 2020;24:191-7. [PMID: 32521994 DOI: 10.7874/jao.2020.00108] [Reference Citation Analysis]
26 Kuo CL, Yen YC, Chang WP, Shiao AS. Association Between Middle Ear Cholesteatoma and Chronic Rhinosinusitis. JAMA Otolaryngol Head Neck Surg 2017;143:757-63. [PMID: 28494066 DOI: 10.1001/jamaoto.2017.0130] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
27 Si Y, Chen YB, Chen SJ, Zheng YQ, Liu X, Liu Y, Jiang HL, Xu G, Li ZH, Huang QH, Xiong H, Zhang ZG. TLR4 drives the pathogenesis of acquired cholesteatoma by promoting local inflammation and bone destruction. Sci Rep 2015;5:16683. [PMID: 26639190 DOI: 10.1038/srep16683] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
28 Benson JC, Carlson ML, Lane JI. MRI of the Internal Auditory Canal, Labyrinth, and Middle Ear: How We Do It. Radiology 2020;297:252-65. [PMID: 32960730 DOI: 10.1148/radiol.2020201767] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
29 Kılıçkaya MM, Aynali G, Tuz M, Bagcı Ö. Is There A Systemıc Inflammatory Effect of Cholesteatoma? Int Arch Otorhinolaryngol 2017;21:42-5. [PMID: 28050207 DOI: 10.1055/s-0036-1584363] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
30 Kuo CL, Shiao AS, Yung M, Sakagami M, Sudhoff H, Wang CH, Hsu CH, Lien CF. Updates and knowledge gaps in cholesteatoma research. Biomed Res Int 2015;2015:854024. [PMID: 25866816 DOI: 10.1155/2015/854024] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 8.0] [Reference Citation Analysis]
31 Samy RN, Earl BR, Lipschitz N, Schweinzger I, Currier M, Cripe T. Engineered oncolytic virus for the treatment of cholesteatoma: A pilot in vivo study. Laryngoscope Investig Otolaryngol 2019;4:532-42. [PMID: 31637298 DOI: 10.1002/lio2.307] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
32 Prasad SC, Giannuzzi A, Nahleh EA, Donato GD, Russo A, Sanna M. Is endoscopic ear surgery an alternative to the modified Bondy technique for limited epitympanic cholesteatoma? Eur Arch Otorhinolaryngol 2016;273:2533-40. [PMID: 26742905 DOI: 10.1007/s00405-015-3883-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
33 Kuo CL. In reference to A new theory on the pathogenesis of acquired cholesteatoma: mucosal traction. Laryngoscope 2016;126:E132. [PMID: 26421908 DOI: 10.1002/lary.25701] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
34 Jovanovic I, Zivkovic M, Djuric T, Stojkovic L, Jesic S, Stankovic A. Perimatrix of middle ear cholesteatoma: A granulation tissue with a specific transcriptomic signature. Laryngoscope 2020;130:E220-7. [PMID: 31132150 DOI: 10.1002/lary.28084] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
35 Khosla S, Elliot M, Donnelly N. Bilateral otoneurological pathology: To operate or not? Cochlear Implants Int 2017;18:121-4. [PMID: 28218014 DOI: 10.1080/14670100.2017.1289605] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
36 Clarke SE, Mistry D, AlThubaiti T, Khan MN, Morris D, Bance M. Diffusion-Weighted Magnetic Resonance Imaging of Cholesteatoma Using PROPELLER at 1.5T: A Single-Centre Retrospective Study. Can Assoc Radiol J 2017;68:116-21. [PMID: 27625184 DOI: 10.1016/j.carj.2016.05.002] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
37 Westerberg J, Tideholm E, Piersiala K, Drakskog C, Kumlien Georén S, Mäki-Torkko E, Cardell LO. JAK/STAT Dysregulation With SOCS1 Overexpression in Acquired Cholesteatoma-Adjacent Mucosa. Otol Neurotol 2021;42:e94-e100. [PMID: 33201080 DOI: 10.1097/MAO.0000000000002850] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Yamamoto-Fukuda T, Akiyama N, Kojima H. Super-enhancer Acquisition Drives FOXC2 Expression in Middle Ear Cholesteatoma. J Assoc Res Otolaryngol 2021;22:405-24. [PMID: 33861394 DOI: 10.1007/s10162-021-00801-7] [Reference Citation Analysis]
39 Randall DR, Park PS, Chau JK. Identification of altered protein abundances in cholesteatoma matrix via mass spectrometry-based proteomic analysis. J Otolaryngol Head Neck Surg 2015;44:50. [PMID: 26608071 DOI: 10.1186/s40463-015-0104-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
40 Iwamoto Y, Nishikawa K, Imai R, Furuya M, Uenaka M, Ohta Y, Morihana T, Itoi-Ochi S, Penninger JM, Katayama I, Inohara H, Ishii M. Intercellular Communication between Keratinocytes and Fibroblasts Induces Local Osteoclast Differentiation: a Mechanism Underlying Cholesteatoma-Induced Bone Destruction. Mol Cell Biol 2016;36:1610-20. [PMID: 27001307 DOI: 10.1128/MCB.01028-15] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
41 McGuire JK, Fagan JJ, Wojno M, Manning K, Harris T. Radiological differences between HIV-positive and HIV-negative children with cholesteatoma. Int J Pediatr Otorhinolaryngol 2018;110:6-11. [PMID: 29859589 DOI: 10.1016/j.ijporl.2018.04.011] [Reference Citation Analysis]
42 Drakskog C, de Klerk N, Westerberg J, Mäki-Torkko E, Georén SK, Cardell LO. Extensive qPCR analysis reveals altered gene expression in middle ear mucosa from cholesteatoma patients. PLoS One 2020;15:e0239161. [PMID: 32915926 DOI: 10.1371/journal.pone.0239161] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Palkó E, Póliska S, Sziklai I, Penyige A. Analysis of KRT1, KRT10, KRT19, TP53 and MMP9 expression in pediatric and adult cholesteatoma. PLoS One 2018;13:e0200840. [PMID: 30021014 DOI: 10.1371/journal.pone.0200840] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 Kurabi A, Cooper M, Spriggs M, Xu Y, Schaerer D, Ryan AF. Molecular Screening Strategy to Identify a Non-invasive Delivery Mechanism for the Treatment of Middle Ear Disorders. Front Med (Lausanne) 2020;7:503819. [PMID: 33392211 DOI: 10.3389/fmed.2020.503819] [Reference Citation Analysis]
45 Fukuda A, Morita S, Nakamaru Y, Hoshino K, Fujiwara K, Homma A. Short-Term Hearing Prognosis of Ossiculoplasty in Pars Flaccida Cholesteatoma Using the EAONO/JOS Staging System. J Int Adv Otol 2019;15:2-7. [PMID: 31058592 DOI: 10.5152/iao.2019.5983] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
46 Leichtle A, Leffers D, Daerr MG, Draf C, Kurabi A, Ryan AF, Rupp J, Bruchhage KL. [Immunomodulation in Cholesteatoma]. Laryngorhinootologie 2021. [PMID: 34233375 DOI: 10.1055/a-1516-4447] [Reference Citation Analysis]
47 Thompson LD. Update From the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Tumours of the Ear. Head Neck Pathol 2017;11:78-87. [PMID: 28247225 DOI: 10.1007/s12105-017-0790-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 3.4] [Reference Citation Analysis]
48 Hamed MA, Nakata S, Shiogama K, Suzuki K, Sayed RH, Nishimura Y, Iwata N, Sakurai K, Badawy BS, Inada KI, Tsuge H, Tsutsumi Y. Cytokeratin 13, Cytokeratin 17, and Ki-67 Expression in Human Acquired Cholesteatoma and Their Correlation With Its Destructive Capacity. Clin Exp Otorhinolaryngol 2017;10:213-20. [PMID: 28073243 DOI: 10.21053/ceo.2016.01263] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
49 Dubernard X, Kleiber JC, Brenet E, Louges MA, Veleine Y, Labrousse M, Makeieff M, Bazin A, Chays A. [The tumors of the ear]. Presse Med 2017;46:1079-88. [PMID: 29097033 DOI: 10.1016/j.lpm.2017.09.016] [Reference Citation Analysis]
50 Kuo CL, Liao WH, Shiao AS. A review of current progress in acquired cholesteatoma management. Eur Arch Otorhinolaryngol 2015;272:3601-9. [PMID: 25227761 DOI: 10.1007/s00405-014-3291-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
51 Kennedy KL, Connolly KM, Albert CL, Goldman JL, Cash ED, Severtson MA. Postoperative Recurrent Cholesteatoma in Rural Versus Urban Populations. Otol Neurotol 2021;42:e459-63. [PMID: 33347050 DOI: 10.1097/MAO.0000000000003003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Presutti L, Anschuetz L, Rubini A, Ruberto M, Alicandri-ciufelli M, Dematte M, Caversaccio M, Marchioni D. The Impact of the Transcanal Endoscopic Approach and Mastoid Preservation on Recurrence of Primary Acquired Attic Cholesteatoma. Otology & Neurotology 2018;39:445-50. [DOI: 10.1097/mao.0000000000001712] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
53 Castle JT. Cholesteatoma Pearls: Practical Points and Update. Head Neck Pathol 2018;12:419-29. [PMID: 30069838 DOI: 10.1007/s12105-018-0915-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
54 Fukuda A, Kano S, Nakamaru Y, Morita S, Hoshino K, Fujiwara K, Homma A. Notch Signaling in Acquired Middle Ear Cholesteatoma. Otol Neurotol 2021. [PMID: 34172659 DOI: 10.1097/MAO.0000000000003245] [Reference Citation Analysis]
55 Ismi O, Karabulut YY, Bal KK, Vayisoglu Y, Unal M. Single dose intratympanic mesna application inhibits propylene glycol induced cholesteatoma formation. J Laryngol Otol 2017;131:215-20. [DOI: 10.1017/s002221511600983x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Yin D, Li C, Juan H, Li J, Yang L, Zhang T, Dai P. Morphological Characteristics of Osseous External Auditory Canal and Its Relationship With External Auditory Canal Cholesteatoma in Patients With Congenital Aural Stenosis. Otol Neurotol 2017;38:1528-34. [PMID: 29065097 DOI: 10.1097/MAO.0000000000001600] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
57 Schürmann M, Greiner JFW, Volland-Thurn V, Oppel F, Kaltschmidt C, Sudhoff H, Kaltschmidt B. Stem Cell-Induced Inflammation in Cholesteatoma is Inhibited by the TLR4 Antagonist LPS-RS. Cells 2020;9:E199. [PMID: 31947538 DOI: 10.3390/cells9010199] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
58 Moneir W, Hemdan A, El-Kholy NA, El-Kotb M, El-Okda M. Endoscopic transcanal attico-antrostomy versus endoscopic-assisted canal wall up mastoidectomy in management of localized cholesteatoma: a randomized clinical trial. Eur Arch Otorhinolaryngol 2021. [PMID: 34851451 DOI: 10.1007/s00405-021-07200-x] [Reference Citation Analysis]
59 Kuo CL, Shiao AS, Wen HC, Chang WP. Increased risk of cholesteatoma among patients with allergic rhinitis: A nationwide investigation. Laryngoscope 2018;128:547-53. [PMID: 28771810 DOI: 10.1002/lary.26220] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
60 Hamed MA, Nakata S, Sayed RH, Ueda H, Badawy BS, Nishimura Y, Kojima T, Iwata N, Ahmed AR, Dahy K, Kondo N, Suzuki K. Pathogenesis and Bone Resorption in Acquired Cholesteatoma: Current Knowledge and Future Prospectives. Clin Exp Otorhinolaryngol 2016;9:298-308. [PMID: 27440129 DOI: 10.21053/ceo.2015.01662] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
61 Takahashi M, Yamamoto-Fukuda T, Akiyama N, Motegi M, Yamamoto K, Tanaka Y, Yamamoto Y, Kojima H. Partial Epithelial-Mesenchymal Transition Was Observed Under p63 Expression in Acquired Middle Ear Cholesteatoma and Congenital Cholesteatoma. Otol Neurotol 2019;40:e803-11. [PMID: 31348131 DOI: 10.1097/MAO.0000000000002328] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
62 Malagutti N, Rotondo JC, Cerritelli L, Melchiorri C, De Mattei M, Selvatici R, Oton-Gonzalez L, Stomeo F, Mazzoli M, Borin M, Mores B, Ciorba A, Tognon M, Pelucchi S, Martini F. High Human Papillomavirus DNA loads in Inflammatory Middle Ear Diseases. Pathogens 2020;9:E224. [PMID: 32197385 DOI: 10.3390/pathogens9030224] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
63 Sunwoo W, Lee SY, Seong J, Han YE, Park MH. Clinical Characteristics of Patients with Cochlear Fistulas Caused by Chronic Otitis Media with Cholesteatoma. J Int Adv Otol 2020;16:40-6. [PMID: 32209518 DOI: 10.5152/iao.2020.7018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Zuo W, Wang F, Yang S, Han D, Dai P, Shen W, Hou Z, Han W. Clinical characteristics of petrosal cholesteatoma and value of MRI-DWI in the diagnosis. Acta Oto-Laryngologica 2020;140:281-5. [DOI: 10.1080/00016489.2019.1701707] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
65 Yamamoto-Fukuda T, Akiyama N. Keratinocyte growth factor signaling promotes stem/progenitor cell proliferation under p63 expression during middle ear cholesteatoma formation. Curr Opin Otolaryngol Head Neck Surg 2020;28:291-5. [PMID: 32796271 DOI: 10.1097/MOO.0000000000000655] [Reference Citation Analysis]
66 Hüttenbrink KB. A new theory interprets the development of a retraction pocket as a natural self-healing process. Eur Arch Otorhinolaryngol 2019;276:367-73. [PMID: 30542765 DOI: 10.1007/s00405-018-5246-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
67 Gong N, Zhu W, Xu R, Teng Z, Deng C, Zhou H, Xia M, Zhao M. Keratinocytes-derived exosomal miRNA regulates osteoclast differentiation in middle ear cholesteatoma. Biochem Biophys Res Commun 2020;525:341-7. [PMID: 32093888 DOI: 10.1016/j.bbrc.2020.02.058] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]